OptiNose, Inc. Soared

OptiNose, Inc. (OPTN:NASDAQ) shot up at $9.15, representing a gain of 52.5%. On Thu, Mar 20, 2025, OPTN:NASDAQ touched a New 2-Week High of $9.15. The stock appeared on our News Catalysts scanner on Thu, Mar 20, 2025 at 10:23 AM in the 'AGREEMENT' category. From Thu, Mar 06, 2025, the stock recorded 44.44% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About OptiNose, Inc. (OPTN:NASDAQ)
OptiNose Inc is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists.
Top 10 Gainers:
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 2042.86%
- IBO (Listing Market - NYSE Amex (IBO:NYSEMKT), 292.45%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 170.06%
- SAG Holdings Limited (SAG:NASDAQ), 73.33%
- F45 Training Holdings Inc. (FXLV:NYSE), 58.73%
- OptiNose, Inc. (OPTN:NASDAQ), 52.5%
- ProAssurance Corporation (PRA:NYSE), 48.13%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 46.25%
- Sunnova Energy International Inc. (NOVA:NYSE), 43.32%
- Outset Medical Inc. (OM:NASDAQ), 36.28%